Pan-cancer analysis reveals DNAJC9 as an immune-related biomarker and a positive regulator of the PI3K/AKT signaling pathway.
Background: Heat shock proteins (HSPs) modulate apoptosis, proliferation, and differentiation, positioning them as potential therapeutic targets in cancer. As a member of the J-domain-containing HSP40 family, DnaJ homolog, subfamily C, member 9 (DNAJC9) has not yet been systematically investigated in a pan-cancer conte...